Today: 27 April 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Tesla Stock (TSLA) News and Forecasts for Dec. 20, 2025: Musk’s Pay Deal Reinstated, Robotaxi Momentum, and Wall Street’s Split Outlook

Tesla Stock (TSLA) News and Forecasts for Dec. 20, 2025: Musk’s Pay Deal Reinstated, Robotaxi Momentum, and Wall Street’s Split Outlook

Tesla shares closed at $481.20 on Dec. 19 after a volatile week, hitting an intraday high of $495.28 before retreating. The Delaware Supreme Court on Dec. 20 reinstated Elon Musk’s 2018 pay package, now worth about $139 billion. Musk’s net worth jumped to $749 billion following the ruling, according to Forbes.
21 December 2025
···
Carnival Corporation & plc Stock (CCL, CUK) Surges as Dividend Returns: Record 2025 Results, 2026 Forecasts, and What Analysts Are Watching

Carnival Corporation & plc Stock (CCL, CUK) Surges as Dividend Returns: Record 2025 Results, 2026 Forecasts, and What Analysts Are Watching

Carnival Corporation shares jumped 9.7% to $31.12 and Carnival plc ADRs surged 17.6% to $30.96 after the company reinstated its quarterly dividend and reported record annual results. Carnival posted $3.1 billion in adjusted net income and $26.6 billion in revenue for the year. The board approved a $0.15 per share dividend, payable February 27, 2026. Management also announced plans to unify its dual-listed share structure.
21 December 2025
····
Cisco Stock (CSCO) News, Forecasts and Analysis: AI Networking Momentum Meets a New Zero‑Day Risk (Dec. 20, 2025)

Cisco Stock (CSCO) News, Forecasts and Analysis: AI Networking Momentum Meets a New Zero‑Day Risk (Dec. 20, 2025)

Cisco shares closed at $78.42 ahead of the Dec. 20 weekend, near multi-decade highs. Morgan Stanley reiterated an Overweight rating, while director Michael D. Capellas disclosed stock sales on Dec. 18 and 19. Cisco Talos reported active exploitation of vulnerabilities in its email security appliances. The company recently raised its fiscal 2026 outlook, citing strong AI networking demand.
21 December 2025
··
Nike Stock (NKE) Outlook: Earnings Beat, Margin Shock, China Reset — Latest News and Forecasts as of Dec. 20, 2025

Nike Stock (NKE) Outlook: Earnings Beat, Margin Shock, China Reset — Latest News and Forecasts as of Dec. 20, 2025

Nike shares fell 10.5% to $58.71 after the company warned of further margin pressure and weak sales in Greater China, despite beating earnings estimates. Fiscal Q2 revenue rose 1% to $12.4 billion, but net income dropped 32% to $792 million. Nike expects gross margins to fall another 175–225 basis points and Q3 revenue to decline in the low-single digits.
21 December 2025
···
Edgewise Therapeutics (EWTX) Stock News, Forecasts and Analysis: What’s Driving the December 2025 Move and What Comes Next

Edgewise Therapeutics (EWTX) Stock News, Forecasts and Analysis: What’s Driving the December 2025 Move and What Comes Next

Edgewise Therapeutics shares surged 20.8% to $25.55 on December 19, 2025, trading over 3.1 million shares after a prior decline. No new company press releases or major updates were issued in the past 24–48 hours. The move followed routine equity grant news on December 2 and Q3 results on November 6. Analyst price targets remain above current levels.
21 December 2025
··
CoreWeave Stock (CRWV) News, Forecasts and Analysis for Dec. 20, 2025: Citi’s Buy Call Fuels a Rally, but 2026 Execution Is the Real Test

CoreWeave Stock (CRWV) News, Forecasts and Analysis for Dec. 20, 2025: Citi’s Buy Call Fuels a Rally, but 2026 Execution Is the Real Test

CoreWeave shares jumped 22.6% to close at $83.00 on Dec. 19, 2025, after Citigroup renewed coverage with a Buy rating and a $135 price target. Trading volume topped 70 million shares. The move followed weeks of concern over data-center delays and debt. Q3 revenue reached $1.36 billion, up 134% year-over-year, but the company remains unprofitable with high interest costs.
21 December 2025
·
Trump Media & Technology Group (DJT) Stock: Latest News, Forecasts and Outlook After the $6 Billion TAE Fusion Deal (Dec. 20, 2025)

Trump Media & Technology Group (DJT) Stock: Latest News, Forecasts and Outlook After the $6 Billion TAE Fusion Deal (Dec. 20, 2025)

Trump Media & Technology Group announced a $6 billion all-stock merger with nuclear fusion firm TAE Technologies, with both companies’ shareholders expected to split ownership evenly. DJT shares surged over 30% on the news, closing Friday, Dec. 19 at $16.09, up 8.28%. The deal is set to close in mid-2026, pending approvals. Devin Nunes and Michl Binderbauer will serve as co-CEOs.
21 December 2025
··
Ondas Holdings (ONDS) Stock: Dec. 20 Weekend Roundup of New Defense Catalysts, Analyst Targets, and What Comes Next

Ondas Holdings (ONDS) Stock: Dec. 20 Weekend Roundup of New Defense Catalysts, Analyst Targets, and What Comes Next

Ondas Holdings shares jumped 18.21% to $9.22 on Friday, Dec. 19, following a series of defense and autonomy updates and the completion of its $81.7 million Roboteam acquisition. The company also announced a new COO and a successful AI demining pilot in Israel. Analyst coverage over the weekend highlighted ONDS as a high-volatility momentum stock.
21 December 2025
·
Rivian Stock (RIVN) Surges Into Dec. 20, 2025: Latest News, Analyst Forecasts, and What Could Drive 2026

Rivian Stock (RIVN) Surges Into Dec. 20, 2025: Latest News, Analyst Forecasts, and What Could Drive 2026

Rivian shares closed near $22.45 on Dec. 20 after heavy trading and a series of autonomy-related headlines. The company announced board member Rose Marcario will step down Jan. 1, 2026, reducing the board to seven. Wedbush raised its price target to $25, citing Rivian’s AI and software push. Rivian also unveiled a custom autonomy chip made with TSMC and launched a new driver-assistance package.
21 December 2025
··
Amicus Therapeutics (FOLD) Stock Jumps on BioMarin’s $4.8B Buyout: Latest News, Forecasts, and Deal Analysis as of Dec. 20, 2025

Amicus Therapeutics (FOLD) Stock Jumps on BioMarin’s $4.8B Buyout: Latest News, Forecasts, and Deal Analysis as of Dec. 20, 2025

BioMarin Pharmaceutical will acquire Amicus Therapeutics in an all-cash deal valued at $4.8 billion, offering $14.50 per share. Amicus stock surged about 30% after the Dec. 19 announcement, trading near $14.18 as of Dec. 20. The deal awaits regulatory and shareholder approval, with closing expected in Q2 2026. Trading volume spiked as investors focused on merger risk and timing.
21 December 2025
··
Warner Bros. Discovery Stock (WBD) Forecast: Netflix Merger vs. Paramount’s $30 Bid Puts Shares in Deal-Driven Limbo (Dec. 20, 2025)

Warner Bros. Discovery Stock (WBD) Forecast: Netflix Merger vs. Paramount’s $30 Bid Puts Shares in Deal-Driven Limbo (Dec. 20, 2025)

Warner Bros. Discovery’s board urged shareholders to reject Paramount Skydance’s $30-per-share all-cash tender offer, citing financing concerns and a potential $4.3 billion cost if the Netflix deal is abandoned. WBD stock closed at $27.77 on Dec. 19, near Netflix’s $27.75 per-share offer. Netflix reaffirmed its commitment to its $72 billion deal. Paramount continues to push its cash bid.
21 December 2025
···
BigBear.ai Stock (BBAI) News, Forecasts and Analyst Views on Dec. 20, 2025: Border-Security Partnership Fuels Momentum as Ask Sage Deal Looms

BigBear.ai Stock (BBAI) News, Forecasts and Analyst Views on Dec. 20, 2025: Border-Security Partnership Fuels Momentum as Ask Sage Deal Looms

BigBear.ai shares surged to $6.26 on Dec. 19, with trading volume topping 218 million after announcing a partnership with radar firm C Speed to deploy its ConductorOS AI platform for real-time threat detection. The company is also in focus over a $250 million Ask Sage acquisition deal and an upcoming share-authorization vote.
21 December 2025
···
Altria (MO) Stock in Focus: FDA Clears on! PLUS Nicotine Pouches, Dividend Dates, and the Latest Analyst Forecasts Into 2026

Altria (MO) Stock in Focus: FDA Clears on! PLUS Nicotine Pouches, Dividend Dates, and the Latest Analyst Forecasts Into 2026

The FDA late Friday authorized marketing of six on! PLUS nicotine pouch products, the first such decision under a new pilot review program. Altria shares closed at $58.07, market cap $97.48 billion, ahead of a key dividend ex-date and after the company confirmed plans to resume retail and online sales for the approved pouches. The authorization covers three flavors in two strengths, with strict packaging and marketing restrictions.
21 December 2025
··
NVIDIA Stock (NVDA) News, Forecasts and Analyst Outlook After Dec. 20, 2025: China Export Review, Blackwell “Cloud Loophole,” and 2026 Catalysts

NVIDIA Stock (NVDA) News, Forecasts and Analyst Outlook After Dec. 20, 2025: China Export Review, Blackwell “Cloud Loophole,” and 2026 Catalysts

Nvidia shares closed near $181 on Dec. 19, 2025, with market cap estimates around $4.4 trillion. Reports surfaced that China’s Tencent may be accessing banned Nvidia Blackwell AI chips via overseas cloud providers. U.S. officials also launched an interagency review that could allow H200 chip sales to China. Wall Street analysts described Nvidia as “cheap” by historical standards.
21 December 2025
·
Uber Stock (NYSE: UBER) News, Forecasts and Analysis on Dec. 20, 2025: Robotaxi Fears, FTC Lawsuit Headlines, and Wall Street’s Next Targets

Uber Stock (NYSE: UBER) News, Forecasts and Analysis on Dec. 20, 2025: Robotaxi Fears, FTC Lawsuit Headlines, and Wall Street’s Next Targets

Uber closed at $79.31 on Dec. 19, 2025, down about 20% from its fall peak but up for the year. The company faces renewed regulatory pressure after the FTC and 21 states filed an amended lawsuit over Uber One practices, sending shares down over 3%. Investors remain focused on legal risks and competition from robotaxis as Uber continues to post profits and expand its platform.
21 December 2025
·
1 … 587 588 589 590 591 … 756

Stock Market Today

  • S&P/TSX Composite Falls Over 100 Points as U.S. Markets Drop
    April 27, 2026, 12:07 PM EDT. Canada's S&P/TSX composite index slid 123.78 points to 33,780.33, pressured by declines in base metal and telecommunications sectors. U.S. markets also retraced, with the Dow Jones down 193.91 points to 49,036.80, the S&P 500 dropping 16.22 points to 7,148.86, and the Nasdaq falling 105.44 points to 24,731.16. The Canadian dollar strengthened slightly to 73.43 U.S. cents. In commodities, June crude oil rose $2.58 to $96.98 per barrel, while June gold futures decreased $52.50 to $4,688.40 an ounce. The mixed movement reflects ongoing volatility across North American financial markets on April 27, 2026.

Latest article

VTI’s Tiny Drop Is Hiding a Bigger Test for U.S. Stocks

VTI’s Tiny Drop Is Hiding a Bigger Test for U.S. Stocks

27 April 2026
Vanguard Total Stock Market ETF edged up 12 cents to $352.17 after an early dip Monday, as investors weighed upcoming mega-cap tech earnings against oil-market risks tied to Iran. The fund remains up 0.59% over the past five days. Oil forecasts rose after Middle East supply concerns, with Goldman Sachs now seeing Brent at $90 a barrel in the fourth quarter. Peer equity ETFs traded mixed in early action.
Nasdaq Pullback Deepens As AI Rally Runs Into Big Tech Earnings, Fed Decision And Oil Shock

Nasdaq Pullback Deepens As AI Rally Runs Into Big Tech Earnings, Fed Decision And Oil Shock

27 April 2026
The Nasdaq Composite fell 0.4% to 24,738.40 Monday after hitting a record, as investors braced for major Big Tech earnings and tracked new OpenAI-linked AI deals. Brent crude jumped 2.44% to $107.90 following stalled U.S.-Iran talks. Microsoft shares dipped after OpenAI ended its exclusive cloud partnership. Qualcomm rose on reports of OpenAI smartphone chip plans.
Intel Stock Rally Is Forcing Wall Street to Rethink the AI Chip Race

Intel Stock Rally Is Forcing Wall Street to Rethink the AI Chip Race

27 April 2026
Intel shares climbed 2.7% to $84.76 on Monday, extending a post-earnings rally that pushed its market value to $430.6 billion. The company reported first-quarter revenue of $13.6 billion, up 7%, with its Data Center and AI unit rising 22% to $5.1 billion. Investors are shifting focus to AI CPUs, though risks remain around supply and Intel’s foundry business.
Go toTop